Gm364 Activators
Transmembrane 9 superfamily member 5 (TM9SF5) activators encompass a variety of chemical compounds that exert their effects by modulating distinct signaling pathways which subsequently influence the activity of TM9SF5. Forskolin, for example, stimulates the production of cAMP, a secondary messenger that activates PKA. The subsequent phosphorylation cascade can enhance the functional activity of TM9SF5 by modifying proteins within its associated pathways. Similarly, genistein indirectly increases the activity of certain tyrosine kinases which can lead to the phosphorylation and activation of proteins that are in the same signaling pathways as TM9SF5, enhancing its activity.
Inhibitors like LY294002, U73122, Gö6976, Chelerythrine, SB203580, PD98059, KN-93, Bisindolylmaleimide I, Okadaic acid, and Calyculin A, each affect different molecular targets within signaling networks, ultimately leading to the functional enhancement of TM9SF5. LY294002, through PI3K inhibition, can indirectly cause an increase in AKT activity, which may affect the trafficking and function of TM9SF5. Similarly, inhibitors of PLC, PKC, MEK, and CaMKII, such as U73122, Gö6976, Chelerythrine, SB203580, PD98059, KN-93, and Bisindolylmaleimide I, can create a cellular environment that compensates by activating alternative pathways or isoforms that interact with or enhance the function of TM9SF5. These alternative signaling events promote the functional activity of TM9SF5 by potentially increasing its phosphorylation state or influencing proteins that regulate TM9SF5 function. Moreover, the use of phosphatase inhibitors like Okadaic acid and Calyculin A underscores a strategy to enhance the activity of TM9SF5 by preventing dephosphorylation. These compounds sustain a heightened phosphorylation status within the cell, which can lead to the persistent activation of TM9SF5. By inhibiting protein phosphatases PP1 and PP2A, Okadaic acid and Calyculin A ensure that proteins within TM9SF5's signaling network remain phosphorylated, thereby supporting an enhanced functional state of TM9SF5.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can increase the activity of certain tyrosine kinases indirectly by inhibiting their negative regulators. This can lead to the phosphorylation of proteins involved in the same pathway as TM9SF5, thus enhancing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by inhibiting PI3K, it can lead to a compensatory increase in AKT phosphorylation. AKT can regulate trafficking and function of membrane proteins, potentially enhancing the activity of TM9SF5. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a selective PKC inhibitor that can lead to the activation of alternative PKC isoforms. These isoforms can phosphorylate cellular proteins that might interact with or regulate TM9SF5, enhancing its functional activity. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a PKC inhibitor that can lead to the activation of alternative pathways that compensate for PKC activity. This compensatory mechanism can enhance the function of proteins involved in the same pathway as TM9SF5. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can lead to the activation of alternative signaling pathways. This may result in the enhancement of proteins that are in the same pathway as TM9SF5, thus increasing its functional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which can lead to the activation of alternative signaling molecules. These molecules may interact with or modify the function of TM9SF5, enhancing its activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a CaMKII inhibitor that can lead to the activation of other CaMK isoforms. These isoforms may phosphorylate proteins that are part of the same pathway as TM9SF5, thus enhancing its functional activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that, through negative feedback, can lead to the activation of alternative signaling pathways. These pathways can enhance the function of TM9SF5. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins. This can enhance the functional activity of TM9SF5 by maintaining its phosphorylated state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like okadaic acid, inhibits protein phosphatases, which leads to increased phosphorylation of proteins within the cell. This heightened phosphorylation state can enhance the activity of TM9SF5. | ||||||